The study of HLA markers susceptibility to celiac disease in women with recurrent pregnancy loss

  • O. I. Terpyliak
  • D. V. Zastavna
  • K. O. Sosnina

Abstract

Aim. Celiac disease (CD) is a multifactorial pathology with high genetic predisposition, and is associated with reproductive health disorders in women. The purpose of the study was to investigate the presence of HLA-DQ2.5 (HLA-DQA1 * 05:01 HLA-DQB1 * 02) and HLA-DQ8 (HLA-DQB1 *03:02) genotypes of predisposition to CD in women with recurrent pregnancy loss. Methods. PCR-SSP (polymerase chain reaction with sequence-specific primers). Results. The increased risk of recurrent pregnancy loss in women is associated with DQ2.5 - the pre-disposition genotype for CD (c2=4.35, P<0,05). Calculation of odds ratio (OR) showed more than 4-fold increase in recurrent pregnancy loss risk in women with HLA-DQ2.5 genotype. Conclusions. The study of HLA markers of celiac disease in women with reproductive loss is important for the purpose of preconceptional prevention of recurrent pregnancy loss.

Keywords: celiac disease, recurrent pregnancy loss, HLA markers.

References

Hachem H., Crepaux V., May-Panloup P., Descamps P., Legendre G., Bouet P.E. Recurrent pregnancy loss: Current perspectives. Int. J. Womens. Health. 2017. Vol. 9. P. 331–345. doi: 10.2147/IJWH.S100817.

Van Den Berg M.M.J., Vissenberg R., Goddijn M. Recurrent Miscarriage Clinics. Obstet. Gyneco.l Clin. North Am. 2014 Vol. 41 (1). P. 145–155. doi: 10.1056/NEJMcp1005330.

Cervera R., Balasch J. Autoimmunity and recurrent pregnancy losses. Clin. Rev. Allergy Immunol. 2010. Vol. 39 (3). P. 148–52. doi: 10.1007/s12016-009-8179-1.

Li T.C., Makris M., Tomsu M., Tuckerman E., Laird S. Recurrent miscarriage: Aetiology, management and prognosis. Hum. Reprod. Update. 2002. Vol. 8 (5). P. 463–481. doi: 10.1093/humupd/8.5.463.

Rull K., Nagirnaja L., Laan M. Genetics of recurrent miscarriage: Challenges, current knowledge, future directions. Front. Genet. 2012. Vol. 3. P. 20894. doi: 10.3389/fgene. 2012.00034.

Hyde K.J., Schust D.J. Genetic considerations in recurrent pregnancy loss. Cold Spring Harb. Perspect Med. 2015. Vol. 5 (3). P. 20894. doi: 10.1101/cshperspect.a023119.

Suzumori N., Sugiura-Ogasawara M. Genetic Factors as a Cause of Miscarriage. Curr. Med. Chem. 2012. Vol. 17 (29). P. 3431–3437. doi: 10.2174/092986710793176302.

Imam S.N., Shamsi M.B., Kumar K., Deka D. Idiopathic Recurrent Pregnancy Loss: Role of Paternal Factors; A Pilot Study. Journal of reproduction and infertility. 2011. P. 20894.

Gilman-Sachs A., Kwak-Kim J., Beaman K.D., Jaiswal M.K., Mallers T.M., Ntrivalas E. Immune Etiology of Recurrent Pregnancy Loss and Its Diagnosis. Am J. Reprod. Immunol. 2012. Vol. 67 (4). P. 319–325. doi: 10.1111/j.1600-0897.2012.01118.x.

Matthiesen L., Kalkunte S., Sharma S. Multiple Pregnancy Failures: An Immunological Paradigm. Am. J. Reprod. Immunol. 2012. Vol. 67 (4). P. 334–340. doi: 10.1111/j.1600-0897.2012.01121.x.

Christiansen O.B., Kolte A.M., Larsen E.C., Nielsen H.S. Immunological causes of recurrent pregnancy loss. Recurrent Pregnancy Loss Evidence-Based Eval Diagnosis Treat 2016. P. 75–88. doi: 10.1007/978-3-319-27452-2_6.

Hyde K.J., Andelin C.O., Schust D.J. Immunology of Isolated and Recurrent Spontaneous Pregnancy Loss. Glob Lib.r Women’s Med. 2014. P. 22281–22337. doi: 10.3843/GLOWM.10320.

Ober C. HLA and Pregnancy: The Paradox of the Fetal Allograft. Am J. Hum. Genet. 2002. Vol. 62 (1). P. 1–5. doi: 10.1086/301692.

Nakagawa K., Kuroda K., Sugiyama R., Yamaguchi K. After 12 consecutive miscarriages, a patient received immunosuppressive treatment and delivered an intact baby. Reprod. Med. Biol. 2017. Vol. 16 (3). P. 297–301. doi: 10.1002/rmb2.12040.

Al-Shamali E., Ashkanani L., Makhseed M., Omu A., Azizieh F., Raghupathy R. Th1 and Th2 cytokine profiles in recurrent aborters with successful pregnancy and with subsequent abortions. Hum. Reprod. 2002. Vol. 16 (10). P. 2219–2226. doi: 10.1093/humrep/16.10.2219.

Dawood F., Farquharson R.G., Stephenson M.D. Investigation of recurrent miscarriage. Early Pregnancy. 2010. P. 59–66. doi: 10.1017/CBO9780511777851.008.

Choudhury S.R. Human reproductive failure II: Immunogenetic and interacting factors. Hum. Reprod. Update .2004. Vol. 7 (2). P. 135–160. doi: 10.1093/humupd/7.2.135.

Freeman H.J. Endocrine manifestations in celiac disease. World J. Gastroenterol. 2016. Vol. 22 (38). P. 8472–8479. doi: 10.3748/wjg.v22.i38.8472.

Levy J., Bernstein L., Silber N. Celiac Disease: An Immune Dysregulation Syndrome. Curr. Probl. Pediatr Adolesc Health Care. 2014. Vol. 44 (11). P. 324–327.

Megiorni F., Pizzuti A. HLA-DQA1 and HLA-DQB1 in Celiac disease predisposition: Practical implications of the HLA molecular typing. Journal of Biomedical Science. 2012. Vol. 19(1). P. 254-8. doi: 10.1186/1423-0127-19-88.

Lal S., Singh P., Arora S., Strand T.A., Makharia G.K. Celiac Disease in Women With Infertility. J. Clin. Gastroenterol. 2015. Vol. 50 (1). P. 33–39. doi: 10.1097/mcg.00000000000 00285.

Soni S., Badawy S.A. Celiac Disease and Its Effect on Human reproduction: A Review. J. Reprod. Med. 2010. Vol. 55 (1–2). P. 3–8.

Casella G., Orfanotti G., Giacomantonio L., Bella C. Di, Crisafulli V., Villanacci V., Baldini V., Bassotti G. Celiac disease and obstetrical-gynecological contribution. 2016. Vol. 9 (4). P. 241–249.

Santonicola A., Iovino P., Cappello C., Capone P., Andreozzi P., Ciacci C. From menarche to menopause: The fertile life span of celiac women. Menopause. 2011. Vol. 18 (10). P. 1125–1130. doi: 10.1097/gme.0b013e3182188421.

Castellani R., Di Simone N., Fattorossi A., de Waure C., De Spirito M., Tersigni C., Gasbarrini A., Scambia G. Celiac disease and reproductive disorders: meta-analysis of epidemiologic associations and potential pathogenic mechanisms. Hum. Reprod. Update. 2014. Vol. 20 (4). P. 582–593. doi: 10.1093/humupd/dmu007.

Saccone G., Berghella V., Sarno L., Maruotti G.M., Cetin I., Greco L., Khashan A.S., McCarthy F., Martinelli D., Fortunato F., Martinelli P. Celiac disease and obstetric complications: A systematic review and metaanalysis. Am. J. Obstet. Gynecol. 2016. Vol. 214 (2). P. 225–234. doi: 10.1016/j.ajog.2015.09.080.

Ozgцr B., Selimoglu M.A. Coeliac disease and reproductive disorders. Scand. J. Gastroenterol. 2010. Vol. 45 (4). P. 395–402. doi: 10.3109/0036552090350890.

Stankoviж B., Radloviж N., Lekoviж Z., Ristiж D., Radloviж V., Nikиeviж G., Kotur N., Vuиiжeviж K., Kostiж T., Pavloviж S., Zukiж B. HLA genotyping in pediatric celiac disease patients. Bosn J. Basic Med. Sci. 2015. Vol. 14 (3). P. 171–176. doi: 10.17305/bjbms.2014.3.28.

Biagi F., Marchese A., Bianchi P.I., Trotta L., Corazza G.R., De Silvestri A., Badulli C., Vattiato C., Martinetti M. Influence of HLA-DQ2 and DQ8 on Severity in Celiac Disease. J. Clin. Gastroenterol. 2011. Vol. 46 (1). P. 46–50. doi: 10.1097/mcg.0b013e318221077e.

Effelsberg N.M., Thiel J., Driever S., Neagu M., Salzer U., Koehn C., Warnatz K., Voll R.E., Goldacker S., Kollert F., Rizzi M., Venhoff N., Kreisel W., Emmerich F. The Role of HLA DQ2 and DQ8 in Dissecting Celiac-Like Disease in Common Variable Immunodeficiency. J. Clin. Immunol. 2013. Vol. 33 (5). P. 909–916. doi: 10.1007/s10875-013-9892-3.

Makukh H.V., Zastavna D.V., Tyrkus M.J., Tretiak B.I., Chorna L.B. Sposib vydilennia DNK z leikocytiv peryferijnoi krovi: pat. 32044 Ukraina: MPK G01N33/49 (2006.01); No. u200801896; appl. 14.02.2008; publ. 25.04.2008, bul. No. 8. [in Ukrainian]

Peterson M., Grossman S. Managing celiac disease for women implications for the primary care provider. Gastroenterol. Nurs. 2016. Vol. 39 (3). P. 186–194. doi: 10.1097/SGA.0000000000000197.